<DOC>
	<DOCNO>NCT01498172</DOCNO>
	<brief_summary>In study , investigator would like assess intravesical BCG schedule immunization non muscle invasive bladder patient recMAGE-A3 protein , together adjuvant AS15 ( recMAGE-A3 + AS15 ASCI ) , may enhance innate vaccine-specific T cell response systemically locally bladder .</brief_summary>
	<brief_title>BCG Modulation recMAGE-A3 + AS15 ASCI Response Treatment Non Muscle Invasive Bladder Cancer ( NMIBC ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>Male female patient histological confirmation NMIBC Full recovery surgery ( TUR ) 1 6 week Karnofsky performance status 60 % Laboratory parameter vital function normal range Women childbearing potential must use adequate contraception negative pregnancy test whole period study treatment administration Male patient avoid behavior lead child conception 2 month administration study treatment Muscle invasive bladder cancer Metastatic disease central nervous system , therapeutic option , include radiotherapy , may available Other serious illness ( e.g. , serious infection require antibiotic , bleed disorder ) Any confirm suspected immunosuppressive immunodeficient condition potential immunemediated disease ( Patients vitiligo exclude participate trial ) History severe allergic reaction vaccine unknown allergen Patients require concomitant chronic treatment systemic corticosteroid immunosuppressive agent . The use prednisone , equivalent , &lt; 0.125 mg/kg/day ( absolute maximum 10 mg/day ) , inhaled corticosteroid topical steroid permit Participation clinical trial involve another investigational agent within 4 week prior first dose study agent Mental impairment may compromise ability give informed consent comply requirement study Lack availability immunological clinical followup assessment For female patient childbearing potential : positive urine serum pregnancy test lactate Known positive HIV test , HBV , HCV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Non muscle invasive bladder cancer</keyword>
</DOC>